Alkermes (ALKS) Profit After Tax (2010 - 2026)

Alkermes' (ALKS) quarterly Profit After Tax came in at -$67.3 million in Q1 2026, down 399.54% year-on-year from $22.5 million in Q1 2025, and down 239.31% on a QoQ basis from $48.3 million in Q4 2025.

Alkermes (ALKS) Profit After Tax (2010 - 2026) Analysis & Trends

Alkermes (ALKS) has 17 years of Profit After Tax data on file, last reported at -$67.3 million in Q1 2026.

  • On a quarterly basis, Profit After Tax fell 399.54% year-over-year to -$67.3 million in Q1 2026; TTM through Mar 2026 was $151.2 million, a 57.13% decrease from a year earlier, with the FY2025 full-year figure at $241.5 million, down 34.2% from the prior year.
  • Profit After Tax for Q1 2026 stood at -$67.3 million, down from $48.3 million in the prior quarter.
  • Over the last five years, Profit After Tax for ALKS reached as high as $237.1 million in Q2 2023 and fell as low as -$67.3 million in Q1 2026.
  • Historically, Profit After Tax has averaged $43.5 million across 5 years, with a median of $48.3 million in 2025.
  • Across the five-year window, Profit After Tax tumbled 3336.43% in 2022 and surged 886.65% in 2023, its largest moves.
  • Year by year, Profit After Tax stood at -$28.3 million in 2022, then soared by 509.65% to $115.7 million in 2023, then rose by 26.58% to $146.5 million in 2024, then plunged by 67.03% to $48.3 million in 2025, then tumbled by 239.31% to -$67.3 million in 2026.
  • Per Business Quant data, the three most recent Profit After Tax figures were -$67.3 million in Q1 2026, $48.3 million in Q4 2025, and $83.1 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 369.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 601.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -2.35 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 274.90 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 176.40 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 197.90 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 57.00 Mn
10 Alkermes 9.72 Bn 9.21 Bn 331.33 Mn -67.29 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -67.29 Mn
Dec 31, 2025 48.30 Mn
Sep 30, 2025 83.10 Mn
Jun 30, 2025 87.10 Mn
Mar 31, 2025 22.46 Mn
Dec 31, 2024 146.50 Mn
Sep 30, 2024 92.38 Mn
Jun 30, 2024 91.36 Mn
Mar 31, 2024 36.83 Mn
Dec 31, 2023 115.74 Mn
Sep 30, 2023 49.12 Mn
Jun 30, 2023 237.07 Mn
Mar 31, 2023 -41.85 Mn
Dec 31, 2022 -28.25 Mn
Sep 30, 2022 -66.32 Mn
Jun 30, 2022 -30.14 Mn
Mar 31, 2022 -35.90 Mn
Dec 31, 2021 873,000.00
Sep 30, 2021 -28.99 Mn
Jun 30, 2021 2.36 Mn